NCT02839811View on ClinicalTrials.gov

Medical Device for Drug Allergy Diagnosis

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Drug Hypersensitivity
Interventions
PROCEDURE

Immediate hypersensitivity to BLC

immediate hypersensitivity to BLC by In vitro diagnosis

Trial Locations (1)

Unknown

University hospital of Montpellier, Montpellier

All Listed Sponsors
collaborator

European Commission

OTHER

lead

University Hospital, Montpellier

OTHER

NCT02839811 - Medical Device for Drug Allergy Diagnosis | Biotech Hunter | Biotech Hunter